Tañeza, Jonalyn S.

HRN: 22-17-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
CEFAZOLIN 1GM (VIAL)
11/06/2022
11/07/2022
IV
2 Vials
Prior To OR
Ectopic Pregnancy
Waiting Final Action 
11/06/2022
CEFAZOLIN 1GM (VIAL)
11/06/2022
11/12/2022
IV
1g
Q8
S/P Pelvic Lap For Ruptured Ectopic Prenancy
Waiting Final Action 
11/09/2022
CEFUROXIME 500MG (TAB)
11/09/2022
11/16/2022
PO
500mg
Q12
S/P Pelvic Laparotomy
Waiting Final Action 
11/09/2022
DOXYCYCLINE 100MG (CAP)
11/09/2022
11/23/2022
PO
1tab
BID
S/p EL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: